Equity Overview
Price & Market Data
Price: $44.45
Daily Change: +$1.05 / 2.37%
Daily Range: $43.79 - $45.09
Market Cap: $0
Daily Volume: 20,180
Performance Metrics
1 Week: 3.09%
1 Month: 6.14%
3 Months: 13.80%
6 Months: 49.67%
1 Year: 197.9%
YTD: 13.60%
Details
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.